Salient points from the CV of Santhi Swaroop Vege, MACG, AGAF, FACP Clinical experience : 45 yrs after completion of fellowship in GI ( ~ 30 yrs at Mayo Clinic, Rochester and 14 yrs atTata Memorial Center, Bombay) Professor of Medicine at Mayo Clinic since 2004 ( 22 years) Bibliography: 1. Over 220 peer reviewed full manuscripts( including JAMA, NEJM, Gastroenterology) 2. Over 100 letters, abstracts, editorials 3. Over 15 book chapters including topics in Up to date for more than 15 years and Sleisenger text book of Gastroenterology Guidelines: 1. Acute pancreatitis Guidelines 2013 and 2024, senior corresponding author for ACG 2. Acute pancreatitis guidelines for APA/IAP 2013 and current IAP 2025 executive member ( in press) 3. Acute pancreatitis technical review for guidelines 2018 senior author AGA 4. Microscopic colitis 2015 AGA 5. ICI GI toxicity (in press) pancreas involvement for ACG 6. Surveillance of Metaplastic and Premalignant Conditions of the GI Tract in the Geriatric Population (in press) for AGA 7. Pancreas cysts 2015 senior author for AGA 8. Revised Atlanta classification on acute pancreatitis 2012 – One of the small working group of authors 9. Lead member for the international group (~ 40) on Revision of revised Atlanta for IAP ACG leadership 1. International governor from India for 2 terms 1992 to 1996. The initial efforts to increase membership for AcG from India 2. Education committee, international committee, more than 1 time and currently active AGA leadership 1. AGA Council member for 5 years 2. AGA Pancreas section vice chair and then chair 2 and 3 years respectively 3. AGA pancreas section councillor current APA leadership 1. Clinical practice guideline committee chair for 2 years 2. Scientific committee member for the combined APA, I AP, JPS meeting December 2024 IAP leadership 1. President 2022, 23, 24 2. Treasurer 2014 to 2018 3. Inducting a new region of the world, Central Asia into IAP with a scientific meeting in 2025 in Baku, Azerbaijan 4. Executive committee member, IAP Mayo Clinic 1. Director pancreas clinic for 8 years prior to 2021 2. Member international committee and regional chair for India and South East Asia for many years 3. Committee member of Education, diversity, practice in internal medicine and gastroenterology in the past Journals 1. American Journal of Gastroenterology- current and past editorial board member 2. Gastroenterology- current and past editorial board member 3. Pancreatology - past associate editor for few years 4. Indian Journal of Gastroenterology editorial board member 5. Reviewer for many decades for journals including NEJM, Annals of surgery, NEJM, Gastroenterology, Amer J Gastroenterol Honors: 1. AGA distinguished clinical researchmentor award pancreas section 2023 2. Master of ACG > 10 years ago 3. Honor every member of Czech gastroenterology Society 4. Henry Plummer distinguished clinician award at Mayo Clinic many years ago 5. Honorary membership in Brazilian College of Surgeons 10 yrs ago 6. Member, WHO scientific advisory board for colorectal cancer 1986 7. James Lipsky Service Award for General Internal Medicine 2005 - Mayo Clinic 8. Excellence in teaching recognition for Internal Medicine Residents 2002-2003 and 2003-2004 - Mayo Clinic 9. Scientific advisor to International Clinical Research Center, Brno, Czech republic for 5 years 10. Outstanding Teacher in Physical Diagnosis - Department of Internal Medicine, Mayo Clinic 2001 Program Director for Advanced fellowship in Medical Pancreatology for 8 yrs ( Only program in the US at that time) More than 30 mentees in leadership positions in universities in India, USA, Mexico Scientific committee member for meetings USA,India, Brazil, Argentina, South Africa, UAE More than 300 key note addresses, orations, invited lectures, oral presentations Visiting professor to national and international universities including Dartmouth, Duke, Cedar Sinai, Emory, Harvard, Wash U, USC, Amsterdam, Rotterdam, Munich, Verona, Kyoto, Tokyo, Dokyo, New Castle, Delhi, Bombay, Hyderabad, Chandigarh, Nanjing, Nanchang, SaoPaulo, Alicante, Heidelberg, Budapest, Brno, Olomouts, Prague amongst others Federal (extra-mural ) grants : 1. R21 NIDDK Pentoxifylline/placebo in acute panreatitis ( published one of the only two drug trials in AP at that time, both by me as PI) 2. DOD grant on pirfenidone in AP RCT with UAB 2022 (ongoing in 2 centers, Mayo PI) 3. NIDDK U01 consortium CPDPC, site PI Mayo, 9 centers (entering last year of second 5 yr cycle) 4. DOD grant on perfenidone in RAP RCT with UAB 2023 ( site PI for Mayo) 5. NIDDK Lacosamide in CP 2022 ( Indiana primary site, Mayo PI) 6. R21 NIDDK Indomethacin in CP PAIR study ( Ohio state and Mayo, PI, completed recruitment) 7. NIDDK U01 consortium T1DAP, Diabetes in AP,2021 ( advisor to California centers) 8. NIDDK CBT in CP 2024 ( Seattle Children primary, Mayo PI) Intra-mural Grants: 1. MIDAS Mayo Clinic for prospective study of AP 2004 2. CP-10 Mayo Clinic Islet cell autotransplantation 2006

Past President of WGO, is currently the Chair of WGO AI Task Force, Head of the Gastroenterology Department in Centro Hospitalar Universitário São Joao- and Full Professor in University of Porto, Portugal. He is the Director of the Gastroenterology and Hepatology WGO Training Center in Porto and was honored with the ACG International Leadership Award in Gastroenterology in 2015 and in 2022 nominated as Master of ACG after serving as president in the Portuguese Societies of Gastroenterology, Endoscopy and Association of Liver Diseases along with the Portuguese Pancreas Club.

Prof Stephen Pereira is a consultant gastroenterologist with special interests in disease of the liver, pancreas and biliary tree, ERCP and endoscopic ultrasound. He completed his undergraduate studies in medicine at University of NSW, Sydney, with postgraduate training in gastroenterology including therapeutic endoscopy mainly at Guy’s and King’s College Hospital, London, and advanced endoscopy training in Paris, Amsterdam and Indianapolis. He has been a consultant at University College London Hospitals since 2000 and at the Royal Free Hospital, London, since 2008 and was appointed Professor of Hepatology & Gastroenterology at UCL in 2015. The research interests of his group centre on the pathogenesis, early diagnosis and novel treatments for biliary tract and pancreatic cancer, as well as benign pancreaticobiliary diseases, with the activity of the research group linked closely with the clinical HPB service at both sites. He leads several multicentre clinical endoscopy trials and translational research studies at UCLH/RFH, including EUS-guided radiofrequency tumour ablation and an early pancreaticobiliary cancer biomarker discovery pipeline.